| Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice V Rhein, X Song, A Wiesner, LM Ittner, G Baysang, F Meier, L Ozmen, ... Proceedings of the National Academy of Sciences 106 (47), 20057-20062, 2009 | 770 | 2009 |
| Best practice in the management of behavioural and psychological symptoms of dementia OP Tible, F Riese, E Savaskan, A von Gunten Therapeutic advances in neurological disorders 10 (8), 297-309, 2017 | 372 | 2017 |
| Post-learning intranasal oxytocin modulates human memory for facial identity E Savaskan, R Ehrhardt, A Schulz, M Walter, H Schächinger Psychoneuroendocrinology 33 (3), 368-374, 2008 | 371 | 2008 |
| Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease E Savaskan, MA Ayoub, R Ravid, D Angeloni, F Fraschini, F Meier, ... Journal of pineal research 38 (1), 10-16, 2005 | 260 | 2005 |
| Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer’s dementia E Savaskan, C Hock, G Olivieri, S Bruttel, C Rosenberg, C Hulette, ... Neurobiology of aging 22 (4), 541-546, 2001 | 260 | 2001 |
| Red wine ingredient resveratrol protects from β-amyloid neurotoxicity E Savaskan, G Olivieri, F Meier, E Seifritz, A Wirz-Justice, F Müller-Spahn Gerontology 49 (6), 380-383, 2003 | 256 | 2003 |
| Dawn–dusk simulation light therapy of disturbed circadian rest–activity cycles in demented elderly PF Gasio, K Kräuchi, C Cajochen, E van Someren, I Amrhein, M Pache, ... Experimental gerontology 38 (1-2), 207-216, 2003 | 211 | 2003 |
| Increased melatonin 1a‐receptor immunoreactivity in the hippocampus of Alzheimer's disease patients E Savaskan, G Olivieri, F Meier, L Brydon, R Jockers, R Ravid, ... Journal of pineal research 32 (1), 59-62, 2002 | 183 | 2002 |
| The effects of β-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and β-amyloid secretion G Olivieri, M Novakovic, E Savaskan, F Meier, G Baysang, M Brockhaus, ... Neuroscience 113 (4), 849-855, 2002 | 159 | 2002 |
| Peripheral mitochondrial dysfunction in Alzheimer’s disease: focus on lymphocytes K Leuner, K Schulz, T Schütt, J Pantel, D Prvulovic, V Rhein, E Savaskan, ... Molecular neurobiology 46, 194-204, 2012 | 151 | 2012 |
| Humour therapy in patients with late‐life depression or Alzheimer's disease: A pilot study M Walter, B Hänni, M Haug, I Amrhein, E Krebs‐Roubicek, ... International Journal of Geriatric Psychiatry: A journal of the psychiatry …, 2007 | 150 | 2007 |
| Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease P Brunner, N Sozer Topcular, R Jockers, R Ravid, D Angeloni, F Fraschini, ... European Journal of Histochemistry 50, 311-316, 2006 | 144 | 2006 |
| Distribution of melatonin MT1 receptor immunoreactivity in human retina E Savaskan, A Wirz-Justice, G Olivieri, M Pache, K Kräuchi, L Brydon, ... Journal of Histochemistry & Cytochemistry 50 (4), 519-525, 2002 | 139 | 2002 |
| Colour vision deficiencies in Alzheimer's disease M Pache, CHW Smeets, PF Gasio, E Savaskan, J Flammer, ... Age and Ageing 32 (4), 422-426, 2003 | 137 | 2003 |
| Melatonin protects SHSY5Y neuroblastoma cells from cobalt‐induced oxidative stress, neurotoxicity and increased β‐amyloid secretion G Olivieri, C Hess, E Savaskan, C Ly, F Meier, G Baysang, M Brockhaus, ... Journal of pineal research 31 (4), 320-325, 2001 | 132 | 2001 |
| Hippocampal estrogen β-receptor immunoreactivity is increased in Alzheimer’s disease E Savaskan, G Olivieri, F Meier, R Ravid, F Müller-Spahn Brain research 908 (2), 113-119, 2001 | 126 | 2001 |
| Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized … E Savaskan, H Mueller, R Hoerr, A von Gunten, S Gauthier International psychogeriatrics 30 (3), 285-293, 2018 | 121 | 2018 |
| The role of the brain renin-angiotensin system in neurodegenerative disorders E Savaskan Current Alzheimer Research 2 (1), 29-35, 2005 | 113 | 2005 |
| Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues E Savaskan, KU Löffler, F Meier, F Müller-Spahn, J Flammer, P Meyer Ophthalmic research 36 (6), 312-320, 2004 | 112 | 2004 |
| Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease E Savaskan, G Olivieri, L Brydon, R Jockers, K Kräuchi, A Wirz-Justice, ... Neuroscience letters 308 (1), 9-12, 2001 | 107 | 2001 |
